Sharon Bio Medicine Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2020. For the quarter, the company reported revenue from operations of INR 358.025 million compared with INR 441.063 million for the same period last year. Profit for the period was INR 14.993 million as compared with loss of INR 687.056 million for the same period last year. Basic EPS was INR 0.13 as compared with INR 0.39 for the same period last year.